Advertisement
Person › Details
Thomas Hecht (Delenex Therapeutics AG)
Hecht, Thomas (Delenex 201105 Board Chairman + Affimed 201112 Board Chairman)
Organisation | Delenex Therapeutics AG | |
Today | Cell Medica Switzerland AG | |
Former/major organisation | Affimed Therapeutics AG | |
Today | Affimed GmbH | |
Group | Affimed (Group) | |
Product | PENTRA® antibody (fragment) technology platform | |
Record changed: 2022-04-15 |
Advertisement
More documents for Thomas Hecht
- [1] Affimed N.V.. (6/16/21). "Press Release: Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board". Heidelberg....
- [2] Cell Medica Ltd.. (12/7/17). "Press Release: Cell Medica Announces Appointment of Industry Leader Dr Annalisa Jenkins as Chair"....
- [3] Aelix Therapeutics S.L.. (10/20/17). "Press Release: Aelix Therapeutics Appoints Dr. Thomas Hecht as Chairman of the Board of Directors"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top